From a baseline of 7.7 % there was no change in HbA1c at 12weeks in the sulphonylurea ( +0.02 % ) compared with a 0.3 % reduction in the liraglutide group ( adjusted coefficient -0.41 , 95 % CI -0.83 , 0.01 , p = 0.05 ) .